Identification of CYP2E1 in marmoset monkey

Area of Science:

• Biochemistry
• Pharmacology
• Immunology

Background:

• Cytochrome P450 2E1 (CYP2E1) is a key enzyme in human liver metabolism.
• CYP2E1 metabolizes chlorzoxazone and is inducible by drugs like isoniazid.
• Understanding CYP2E1 in non-human primates is vital for preclinical drug development.

Purpose of the Study:

• To investigate the presence and characteristics of CYP2E1 in marmoset liver.
• To determine if marmoset CYP2E1 differs antigenically from human and cynomolgus monkey CYP2E1.
• To explore the structural basis for species-specific antibody recognition of CYP2E1.

Main Methods:

• Enzyme kinetic studies using chlorzoxazone 6-hydroxylase activity.
• Immunochemical analysis with anti-peptide antibodies against human/cynomolgus CYP2E1.
• Sequencing of marmoset CYP2E1 cDNA to analyze the C-terminal region.
• Generation and testing of a novel antibody against marmoset CYP2E1 C-terminus.

Main Results:

• Marmoset liver microsomes exhibit chlorzoxazone 6-hydroxylase activity similar to humans, inducible by isoniazid.
• An antibody against human/cynomolgus CYP2E1 C-terminus did not bind marmoset CYP2E1.
• Marmoset CYP2E1 C-terminus is extended by two amino acids (Ser-Val) compared to human/cynomolgus.
• A newly generated antibody specifically recognized marmoset CYP2E1, confirming its presence and induction.

Conclusions:

• CYP2E1 is present and functionally active in marmoset liver, with inducible expression.
• The extended C-terminus of marmoset CYP2E1 explains the lack of cross-reactivity with antibodies raised against other species.
• This study underscores the significance of C-terminal amino acid sequences in P450 enzyme antibody specificity.